ATE378426T1 - Neue sequenz um die expression einer nukleinsäure zu erhöhen - Google Patents

Neue sequenz um die expression einer nukleinsäure zu erhöhen

Info

Publication number
ATE378426T1
ATE378426T1 AT05756870T AT05756870T ATE378426T1 AT E378426 T1 ATE378426 T1 AT E378426T1 AT 05756870 T AT05756870 T AT 05756870T AT 05756870 T AT05756870 T AT 05756870T AT E378426 T1 ATE378426 T1 AT E378426T1
Authority
AT
Austria
Prior art keywords
expression
nucleic acid
increase
new sequence
repressor
Prior art date
Application number
AT05756870T
Other languages
German (de)
English (en)
Inventor
Arie Otte
Theodorus Kwaks
Richard George Antonius Sewalt
Blokland Henricus Johannes Van
Original Assignee
Chromagenics Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34971366&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE378426(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chromagenics Bv filed Critical Chromagenics Bv
Application granted granted Critical
Publication of ATE378426T1 publication Critical patent/ATE378426T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT05756870T 2004-07-08 2005-07-07 Neue sequenz um die expression einer nukleinsäure zu erhöhen ATE378426T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58700704P 2004-07-08 2004-07-08
EP2004051405 2004-07-08

Publications (1)

Publication Number Publication Date
ATE378426T1 true ATE378426T1 (de) 2007-11-15

Family

ID=34971366

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05756870T ATE378426T1 (de) 2004-07-08 2005-07-07 Neue sequenz um die expression einer nukleinsäure zu erhöhen

Country Status (19)

Country Link
US (1) US7825232B2 (OSRAM)
JP (1) JP4805262B2 (OSRAM)
KR (1) KR101188013B1 (OSRAM)
CN (1) CN1981057B (OSRAM)
AT (1) ATE378426T1 (OSRAM)
AU (1) AU2005261699B2 (OSRAM)
BR (1) BRPI0512798A (OSRAM)
CA (1) CA2573022C (OSRAM)
DE (1) DE602005003369T2 (OSRAM)
DK (1) DK1763586T3 (OSRAM)
EA (1) EA011747B1 (OSRAM)
ES (1) ES2296201T3 (OSRAM)
IL (1) IL180531A (OSRAM)
MX (1) MXPA06014553A (OSRAM)
NO (1) NO341862B1 (OSRAM)
NZ (1) NZ551510A (OSRAM)
PT (1) PT1763586E (OSRAM)
WO (1) WO2006005718A2 (OSRAM)
ZA (1) ZA200610470B (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004056986A2 (en) 2002-12-20 2004-07-08 Chromagenics B.V. Means and methods for producing a protein through chromatin openers that are capable of rendering chromatin more accessible to transcription factors
US8999667B2 (en) * 2004-11-08 2015-04-07 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20060195935A1 (en) 2004-11-08 2006-08-31 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20100136616A1 (en) * 2004-11-08 2010-06-03 Chromagenics B.V. Selection of Host Cells Expressing Protein at High Levels
AU2005300503B2 (en) * 2004-11-08 2010-12-16 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20060172382A1 (en) * 2004-11-08 2006-08-03 Chromagenics B.V. Selection of host cells expressing protein at high levels
US8039230B2 (en) 2004-11-08 2011-10-18 Chromagenics B.V. Selection of host cells expressing protein at high levels
WO2010147464A1 (en) 2009-06-15 2010-12-23 Cellagenics B.V. Use of a cysteine synthesizing enzyme as selectable marker
EP2582816B1 (en) 2010-06-15 2017-12-20 Cellagenics B.V. Novel intergenic elements for enhancing gene expression
US9650630B2 (en) 2010-09-01 2017-05-16 Cellagenics B.V. Nucleic acid fragments from a ribosomal protein promoter for enhancing gene expression
CN110484563B (zh) * 2019-07-25 2023-04-07 新乡医学院 哺乳动物细胞组合表达载体、表达系统、制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE466943T1 (de) * 2001-07-04 2010-05-15 Chromagenics Bv Dns-sequenzen mit anti-repressor aktivität
AU2003238719B2 (en) * 2002-06-14 2008-02-21 Chromagenics B.V. A method for simultaneous production of multiple proteins, vectors and cells for use therein
WO2004056986A2 (en) * 2002-12-20 2004-07-08 Chromagenics B.V. Means and methods for producing a protein through chromatin openers that are capable of rendering chromatin more accessible to transcription factors

Also Published As

Publication number Publication date
BRPI0512798A (pt) 2008-04-08
ZA200610470B (en) 2008-09-25
NO341862B1 (no) 2018-02-12
US20070212755A1 (en) 2007-09-13
US7825232B2 (en) 2010-11-02
EA200700233A1 (ru) 2007-06-29
PT1763586E (pt) 2008-02-25
DE602005003369D1 (de) 2007-12-27
DE602005003369T2 (de) 2009-03-05
ES2296201T3 (es) 2008-04-16
CN1981057A (zh) 2007-06-13
JP2008505626A (ja) 2008-02-28
NZ551510A (en) 2009-10-30
NO20070757L (no) 2007-02-08
AU2005261699B2 (en) 2009-07-23
DK1763586T3 (da) 2008-03-17
WO2006005718A3 (en) 2006-08-17
KR101188013B1 (ko) 2012-10-08
CN1981057B (zh) 2012-07-04
MXPA06014553A (es) 2007-03-12
KR20070042122A (ko) 2007-04-20
WO2006005718A2 (en) 2006-01-19
CA2573022C (en) 2012-03-06
AU2005261699A1 (en) 2006-01-19
EA011747B1 (ru) 2009-06-30
IL180531A0 (en) 2007-06-03
CA2573022A1 (en) 2006-01-19
IL180531A (en) 2011-04-28
JP4805262B2 (ja) 2011-11-02
HK1097004A1 (en) 2007-06-15

Similar Documents

Publication Publication Date Title
NO20070757L (no) Ny sekvens for forbedring av ekspresjon av nukleinsyre(r)
DK1836299T4 (da) Polypeptider, der har cellobiohydrolaseaktivitet, og polynukleotider, der koder for disse
DK1448595T3 (da) Antimikrobielle polypeptider
WO2006039541A3 (en) Polypeptides having lipase activity and polynucleotides encoding same
DK1578964T4 (da) Polypeptider med cellobiohydrolase II-aktivitet og polynukleotider, der koder for samme
DE60042775D1 (de) Verbesserte sequenzierung mittels hybridisierung durch verwendung von sondengemischen
WO2006047469A8 (en) Polypeptides having lipase activity and polynucleotides encoding same
EP1692255A4 (en) EXTRACTION OF NUCLEIC ACID FROM EPITHELIAL CELLS FROM THE MOUTH
EP1472265A4 (en) RNA INTERFERENCE MEDIA INHIBITION OF THE EXPRESSION OF THE POLYCOMB GROUP EZH2 PROTEIN GENE USING A SHORT INTERFERING NUCLEIC ACID (SINA)
IS8035A (is) Nýir ljósóstöðugir verndarhópar til bættra aðferða við að framleiða fákirnafylkingar
ATE407939T1 (de) 2ß-NITROBENZYL-MODIFIZIERTE RIBONUKLEOTIDE
EA200701738A1 (ru) Способ получения транс-1-((1r,3s)-6-хлор-3-фенилиндан-1-ил)-3,3-диметилпиперазина
ATE488591T1 (de) Neuer l-lysin-induzierbarer promotor
DE60123334D1 (de) Methode für die Produktion von Nukleotiden durch Fermentierung
DK1851320T3 (da) Vacciner på basis af anvendelsen af MVA
DE602005017034D1 (de) Signalpeptid zur herstellung eines polypeptids
WO2008002548A3 (en) Novel human acidic mammalian chitinase and use thereof
DK1963514T3 (da) Fremgangsmåder til fototransferering af nukleinsyre til levende celler
DE602006014001D1 (de) Herstellung von 2-aminothiazol-5-carbonsäurederivaten
DK1226236T3 (da) Polypeptider, der har glucanotransferase-aktivitet, og nucleinsyrer, som koder disse
DK1208213T3 (da) Fremgangsmåde til fremstilling af proteiner i værtsceller under anvendelse af chaperoniner
ATE414905T1 (de) Diabetesmodell
EP1721907A4 (en) SILYLIC COUPLING AGENT FOR SOLID PHASE SYNTHESIS OF NUCLEIC ACID
WO2005067649A3 (en) Use of databases to create gene expression microarrays
EA200702009A1 (ru) Усовершенствованный способ экспрессирующего клонирования в клетке-хозяине

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1763586

Country of ref document: EP